Tomás José González‐López

2.4k total citations
43 papers, 424 citations indexed

About

Tomás José González‐López is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomás José González‐López has authored 43 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 12 papers in Genetics and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomás José González‐López's work include Platelet Disorders and Treatments (28 papers), Blood groups and transfusion (21 papers) and Blood properties and coagulation (9 papers). Tomás José González‐López is often cited by papers focused on Platelet Disorders and Treatments (28 papers), Blood groups and transfusion (21 papers) and Blood properties and coagulation (9 papers). Tomás José González‐López collaborates with scholars based in Spain, United Kingdom and United States. Tomás José González‐López's co-authors include José Ramón González‐Porras, Blanca Sánchez‐González, María Eva Mingot‐Castellano, Cristina Pascual, Drew Provan, Abelardo Bárez, Erik de Cabo, Marı́a Luisa Lozano, Nuria Revilla and Marc Michel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cardiovascular Research.

In The Last Decade

Tomás José González‐López

41 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomás José González‐López Spain 11 318 90 86 64 54 43 424
Shinya Katsutani Japan 10 245 0.8× 51 0.6× 46 0.5× 42 0.7× 56 1.0× 21 334
Horia Bumbea Romania 12 229 0.7× 144 1.6× 104 1.2× 29 0.5× 31 0.6× 70 462
Nuria Revilla Spain 10 208 0.7× 44 0.5× 33 0.4× 34 0.5× 28 0.5× 18 278
Michihiro Uchiyama Japan 9 276 0.9× 107 1.2× 41 0.5× 45 0.7× 56 1.0× 41 420
Orna Shamai‐Lubovitz Israel 6 299 0.9× 65 0.7× 135 1.6× 57 0.9× 44 0.8× 11 452
Nayla Boulad United States 5 392 1.2× 84 0.9× 134 1.6× 43 0.7× 25 0.5× 8 464
Ayanbola Elegbe United States 8 142 0.4× 104 1.2× 80 0.9× 16 0.3× 30 0.6× 22 424
Hava Üsküdar Teke Türkiye 11 106 0.3× 56 0.6× 44 0.5× 36 0.6× 31 0.6× 53 273
M. Graubner Germany 8 224 0.7× 70 0.8× 40 0.5× 64 1.0× 28 0.5× 18 315
Catherine Trichet France 9 169 0.5× 30 0.3× 19 0.2× 44 0.7× 47 0.9× 13 292

Countries citing papers authored by Tomás José González‐López

Since Specialization
Citations

This map shows the geographic impact of Tomás José González‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás José González‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás José González‐López more than expected).

Fields of papers citing papers by Tomás José González‐López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás José González‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás José González‐López. The network helps show where Tomás José González‐López may publish in the future.

Co-authorship network of co-authors of Tomás José González‐López

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás José González‐López. A scholar is included among the top collaborators of Tomás José González‐López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás José González‐López. Tomás José González‐López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Provan, Drew, et al.. (2024). Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?. Advances in Therapy. 41(10). 3771–3777. 1 indexed citations
2.
Fattizzo, Bruno, Andreas Glenthøj, Marc Michel, et al.. (2023). Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience. Blood. 141(16). 2016–2021. 8 indexed citations
3.
González‐López, Tomás José, Adrian C. Newland, & Drew Provan. (2023). Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View. Medicina. 59(4). 815–815. 5 indexed citations
4.
González‐López, Tomás José, Drew Provan, Abelardo Bárez, et al.. (2023). Primary and secondary immune thrombocytopenia (ITP): Time for a rethink. Blood Reviews. 61. 101112–101112. 18 indexed citations
5.
González‐López, Tomás José, et al.. (2023). European Delphi panel to build consensus on tapering and discontinuing thrombopoietin receptor agonists in immune thrombocytopenia. Platelets. 34(1). 2170999–2170999. 3 indexed citations
6.
Mingot‐Castellano, María Eva, José María Bastida, Tomás José González‐López, et al.. (2022). Novel Therapies to Address Unmet Needs in ITP. Pharmaceuticals. 15(7). 779–779. 12 indexed citations
7.
Fattizzo, Bruno, Giulio Giordano, Andrea Patriarca, et al.. (2022). Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience. Blood. 140(7). 789–792. 4 indexed citations
8.
González‐López, Tomás José & Drew Provan. (2022). Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP). Advances in Therapy. 39(6). 2287–2291. 6 indexed citations
9.
González‐López, Tomás José, Abelardo Bárez, Silvia Bernat, et al.. (2022). Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group. Infectious Diseases and Therapy. 12(2). 303–315. 4 indexed citations
10.
Mingot‐Castellano, María Eva, et al.. (2022). COVID-19 Vaccines and Autoimmune Hematologic Disorders. Vaccines. 10(6). 961–961. 34 indexed citations
11.
12.
Mingot‐Castellano, María Eva, María Román, Tomás José González‐López, et al.. (2019). Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group. Advances in Hematology. 2019. 1–11. 5 indexed citations
13.
Lozano, Marı́a Luisa, María Eva Mingot‐Castellano, María Perera, et al.. (2019). Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study. Blood. 134(Supplement_1). 1088–1088. 1 indexed citations
14.
Revilla, Nuria, Javier Corral, Antonia Miñano, et al.. (2018). Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content. Platelets. 30(6). 743–751. 49 indexed citations
15.
Jiménez, Cristina, María García‐Álvarez, Miguel Alcoceba, et al.. (2018). Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study. Annals of Hematology. 97(3). 475–484. 17 indexed citations
16.
González‐López, Tomás José, Fernando Fernández‐Fuertes, José‐Ángel Hernández‐Rivas, et al.. (2017). Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice. International Journal of Hematology. 106(4). 508–516. 35 indexed citations
17.
Guruceaga, Elizabeth, Ibai Tamayo, José Ramón González‐Porras, et al.. (2016). Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk. Cardiovascular Research. 110(3). 309–318. 30 indexed citations
18.
Ruíz, Miguel A., José Ramón González‐Porras, Eduardo Franco, et al.. (2013). Further Validation of a New Questionnaire to Measure Satisfaction with Medical Care in Patients with Atrial Fibrillation (SAFUCA) in Spain. Value in Health. 16(7). A535–A535. 1 indexed citations
19.
González‐Porras, José Ramón, Fernando Escalante, Emilia Pardal, et al.. (2013). Safety and efficacy of splenectomy in over 65‐yrs‐old patients with immune thrombocytopenia. European Journal Of Haematology. 91(3). 236–241. 47 indexed citations
20.
González‐López, Tomás José, Lourdes Vázquez, Teresa Flores, Jesús F. San Miguel, & Ramón García‐Sánz. (2011). Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation. SHILAP Revista de lepidopterología. 1(4). e95–e95. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinya Katsutani Breakdown of academic impact, for papers by Horia Bumbea Breakdown of academic impact, for papers by Nuria Revilla Breakdown of academic impact, for papers by Michihiro Uchiyama Breakdown of academic impact, for papers by Orna Shamai‐Lubovitz Breakdown of academic impact, for papers by Nayla Boulad Breakdown of academic impact, for papers by Ayanbola Elegbe Breakdown of academic impact, for papers by Hava Üsküdar Teke Breakdown of academic impact, for papers by M. Graubner Breakdown of academic impact, for papers by Catherine Trichet
Rankless by CCL
2026